Inventor · disambiguated record
Eduardo Muñoz Blanco
Also filed as: MUNOZ BLANCO EDUARDO · MUÑOZ BLANCO EDUARDO
6 granted patents·5 pending applications·5 citations·filing 2008–2022
71Inventor score
Files withEMERALD HEALTH PHARMACEUTICALS INC3INDENA SPA2VIVACELL BIOTECHNOLOGY ESPAÑA S L2MU OZ BLANCO EDUARDO1VIVACELL BIOTECHNOLOGY ESPANA1
Top patents by PatentIndex Score
11 records- 0169US9701618B2Cannabidiol quinone derivativesVIVACELL BIOTECHNOLOGY ESPAÑA S L·Filed 2014·Granted Jul 11, 2017·3 cites·7 claims
- 0263US8772349B2Cannabinoid quinone derivativesMU OZ BLANCO EDUARDO·Filed 2010·Granted Jul 8, 2014·2 cites·8 claims
- 0358US11583506B1Cannabinoids for use in suppressing cancer stem cellsVIVACELL BIOTECHNOLOGY ESPANA S L U·Filed 2022·Granted Feb 21, 2023·0 cites·9 claims
- 0458US9416083B2Method of isolating ingenolINDENA SPA·Filed 2015·Granted Aug 16, 2016·0 cites·7 claims
- 0553US2014243551A1Method of isolating ingenolINDENA SPA·Filed 2012·Application pending·0 cites
- 0650US2021317070A1Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activityEMERALD HEALTH PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0746US10919843B2Cannabidiol derivatives as inhibitors of the HIF prolyl hydroxylases activityEMERALD HEALTH PHARMACEUTICALS INC·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 0843US2010222437A1Composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseasesVIVACELL BIOTECHNOLOGY ESPANA·Filed 2008·Application pending·0 cites
- 0941US2022226259A1Cannabinoids for use in supressing cancer stem cellsVIVACELL BIOTECHNOLOGY ESPANA S L·Filed 2020·Application pending·0 cites
- 1040US2022041538A1Cannabigerol quinone acid and salts thereofEMERALD HEALTH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1128US9802880B2Cannabigerol derivativesVIVACELL BIOTECHNOLOGY ESPAÑA S L·Filed 2015·Granted Oct 31, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Eduardo Muñoz Blanco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →